UBS Maintains a 'Neutral' on Bruker Corp (BRKR); Sees Acquisition of Varian Assets Accretive to 2010-11
Tweet Send to a Friend
UBS maintains a 'Neutral' rating on Bruker Corp (Nasdaq: BRKR), raises price target from $14 to $15.
UBS analyst sees ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst sees ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
